biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.89−0.10 (-10.51%)
Close on Nov 18, 2026Market cap $31.83MP/E 8.9Yield –
biote operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
biote's operating income for the twelve months ending Jun 30, 2026 was $14.75M, down 58.3% year over year. For fiscal 2025 it was $35.55M, up 12.5% from the year before. The highest annual figure on record is $35.55M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.55M | +12.5% |
| FY2024 | Dec 31, 2024 | $31.61M | +10.3% |
| FY2023 | Dec 31, 2023 | $28.66M | – |
| FY2022 | Dec 31, 2022 | -$60.72M | -275.7% |
| FY2021 | Dec 31, 2021 | $34.56M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.51M | -132.6% |
| Q1 FY2026 | Mar 31, 2026 | $3.17M | -67.3% |
| Q4 FY2025 | Dec 31, 2025 | $6.83M | +146.8% |
| Q3 FY2025 | Sep 30, 2025 | $8.27M | -32.1% |
| Q2 FY2025 | Jun 30, 2025 | $10.77M | +72.7% |
| Q1 FY2025 | Mar 31, 2025 | $9.69M | -7.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.77M | -49.8% |
| Q3 FY2024 | Sep 30, 2024 | $12.18M | +60.3% |
| Q2 FY2024 | Jun 30, 2024 | $6.23M | -18.7% |
| Q1 FY2024 | Mar 31, 2024 | $10.43M | +32.3% |
| Q4 FY2023 | Dec 31, 2023 | $5.51M | -24.6% |
| Q3 FY2023 | Sep 30, 2023 | $7.60M | -2.8% |
| Q2 FY2023 | Jun 30, 2023 | $7.67M | – |
| Q1 FY2023 | Mar 31, 2023 | $7.88M | -19.3% |
| Q4 FY2022 | Dec 31, 2022 | $7.30M | +23.3% |
| Q3 FY2022 | Sep 30, 2022 | $7.82M | -13.0% |
| Q2 FY2022 | Jun 30, 2022 | -$85.60M | -934.3% |
| Q1 FY2022 | Mar 31, 2022 | $9.76M | – |
| Q4 FY2021 | Dec 31, 2021 | $5.93M | – |
| Q3 FY2021 | Sep 30, 2021 | $8.98M | – |
| Q2 FY2021 | Jun 30, 2021 | $10.26M | – |
| Q1 FY2021 | Mar 31, 2021 | -$107.88K | – |
See a number that looks wrong?